Not applicableUnknownNCT01250665
What this trial is testing
Study Comparing Corpus Callosum Atrophy as a Marker of Later Development of Cognitive Impairment in Patients With Multiple Sclerosis
Who this might be right for
Multiple SclerosisCognitive Impairment
Cantonal Hospital of St. Gallen 65